+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

M

Actively Recruiting

Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.

Age: 18Years +All Genders
2393 locations
P

Actively Recruiting

Healthy Volunteer

This research aims to evaluate the use and safety of Motiva Implants in people undergoing breast implant procedures. The study focuses on collecting and assessing safety and effectiveness data about these implants after they have been approved and are in general use. It includes participants who have primary breast augmentation, revision breast augmentation, or other aesthetic surgeries, with a focus on female patients aged 22 and older. Participants will receive Motiva Implants as part of their breast surgery or undergo other aesthetic procedures. The study is prospective and non-randomized, with data collected at baseline before surgery, during the operation, and annually for up to 10 years after surgery. Participants who have revision surgery or other aesthetic procedures without implants are also included as control groups to compare outcomes. During the study, participants will have various assessments including medical imaging such as CT, ultrasound, or MRI if medically advised. Researchers will monitor for connective tissue disease signs and symptoms, reproductive complications, cancer diagnoses, local complications, and patient satisfaction over 10 years. The impact of RFID on imaging will also be assessed. Participants will be followed for up to 10 years, providing long-term data on the safety and performance of Motiva Implants.

Age: 22Years +FEMALEPhase Not Applicable
33 locations
E

Actively Recruiting

Researchers are evaluating the safety and effectiveness of the CORUS-LX device as an addition to lumbar interbody fusion surgery for patients with degenerative lumbosacral disc disease requiring two-level lumbar fusion at L4-S1. This study aims to determine whether the use of the CORUS-LX device improves fusion success, reduces major device-related adverse events, and decreases the need for injections or revision surgeries compared to standard minimally invasive supplemental posterior fusion. Participants will undergo two-level lumbar interbody fusion at L4-L5 and L5-S1 segments. They will be randomly assigned to receive supplemental posterior fusion using either the study device CORUS-LX with pedicle screw and rod fixation or the standard minimally invasive technique with pedicle screw and rod fixation. Both procedures involve the use of navigation technology for placing posterior instrumentation. The study includes a post-market, randomized controlled trial design with two arms the treatment arm using the study device and the control arm using the standard technique. Participants will have a screening and baseline visit, followed by surgery for their assigned intervention. After surgery, they will attend five follow-up visits at 6 weeks, 3 months, 6 months, 12 months, and 24 months. During these visits, they will complete surveys about their outcomes and undergo standard care procedures. Researchers will measure fusion success at 12 months, freedom from serious device-related adverse events, and freedom from injections or revision surgeries related to back or leg pain. The study will also explore additional outcomes such as interbody bridging bone, range of motion, and disc height changes through 24 months.

Age: 18Years - 80YearsAll GendersPhase Not Applicable
12 locations